Cost-effective treatment with half year of trastuzumab and chemotherapy as adjuvant treatment for overexpression of Her2/neu breast cancer patients: Two institutional experiences in Taiwan

吳志雄Tai CJ; Pan CK; Wu CH; Chen CS; ;2026-05-202026-05-202006https://203.71.86.71/handle/123456789/18626en-US外科學科會議論文Cost-effective treatment with half year of trastuzumab and chemotherapy as adjuvant treatment for overexpression of Her2/neu breast cancer patients: Two institutional experiences in Taiwanconference